Tabula Rasa HealthCare (TRHC) Misses Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tabula Rasa HealthCare Reports Second Quarter 2022 Results
August 4, 2022 4:30 PM EDTRevenue from continuing operations of $72.6 million increased 13% vs. a year ago, driven by CareVention HealthCare revenue growth of 17%.GAAP net loss from continuing operations of $12.7 million vs. $14.1 million a year ago and $20.4 million in Q1 2022.Adjusted EBITDA from continuing operations of $2.1 million vs. $3.3 million a year ago and $1.1 million in Q1 2022.Cash of $26.5 million as of June 30, 2022, up $12.1 million on a sequential basis vs. Q1 2022.
MOORESTOWN, N.J., Aug. 4, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (Nasdaq: TRHC), a leading healthcare technology company advancing the safe... More



